IRVING, Texas — With the end of a career spanning almost four decades of involvement in community pharmacy close at hand, Chris Dimos remains as optimistic about the business and the meaningful contributions it can make to health care delivery as when he earned a pharmacy degree from Purdue University in 1988. Dimos — who
Colleen Lindholz, president of Kroger Co.’s health care business, talks about the company’s response to COVID-19, the evolution of community pharmacy, the link between health and nutrition, and the move toward value-based care.
In the latest installment in our Video Forum series, Randy Edeker, chairman, president and chief executive officer of Hy-Vee Inc., talks about the food/drug combination store operator’s response to the unprecedented challenges of recent months, the need to take care of customers and staffers, and retailing in an omnichannel world.
One characteristic Ornella Barra has evinced throughout her career in community pharmacy and drug wholesaling is the ability to adapt to changing conditions. That talent has served Walgreens Boots Alliance’s co-chief operating officer well in recent months: Both before and after the emergence of COVID-19, she has been a catalyst for innovation. A good example
The latest installment in our Video Forum features Scott Melville, president and chief executive officer of the Consumer Healthcare Products Association. In addition to the rebranding of CHPA, Melville talks about what recently enacted O-T-C monograph reform means for the category, and the increasingly important part that nonprescription products are playing in health care.
In the latest installment of our Video Forum, Rich Tremonte, executive vice president and president of community and specialty pharmacy at AmerisourceBergen, discusses the company’s success in keeping the pharmaceutical supply chain on track during the outbreak of the novel coronavirus, pharmacy retailers’ stepped-up efforts to meet the needs of patients, and the Good Neighbor
WASHINGTON — Coming off one of the most significant public policy victories in its 139-year history, the Consumer Healthcare Products Association (CHPA) is updating its brand image and revamping its structure to better reflect the expanding scope of the over-the-counter health care sector. “We asked our members what we want to be, who we want
Rite Aid’s ongoing turnaround efforts have been complicated by the arrival of COVID-19. In the second of Chain Drug Review’s new series of video interviews, chief operating officer Jim Peters shares his insights about the company’s robust response to the pandemic and the core elements of the plan designed to revitalize and extend Rite Aid’s
President Trump held a press briefing in the White House Rose Garden last month to formally launch Operation Warp Speed, a public-private program intended to foster the development of pharmaceuticals to combat the novel coronavirus. During the event, Trump reiterated his pledge that a vaccine that prevents COVID-19 will be available to Americans by the
DEERFIELD, Ill. – With Richard Ashworth’s resignation as Walgreens president to lead Tivity Health Inc., one thread in the drug chain’s storied history is coming to an end, even as the overarching narrative of its transformation continues. Ashworth – whose duties are being assumed by Walgreens Boots Alliance co-chief operating officer Alex Gourlay, whom he
ARLINGTON, Va. – Rick Keyes, president and chief executive officer of Meijer Inc., has succeeded Richard Ashworth as chairman of the National Association of Chain Drug Stores. Triggered by Ashworth’s resignation as Walgreens president to become CEO at Tivity Health Inc., the transition adheres to the association’s long-established succession plan. Keyes, who had been NACDS
Entrenched assumptions about the role of community pharmacy are being uprooted by the COVID-19 crisis, and leaders of five of the nation’s largest retailers accelerated the process last month during a meeting with President Trump and the Coronavirus Task Force at the White House. The executives were there to lend support to the public-private partnership
The COVID-19 pandemic has placed unprecedented demands on retail pharmacies. In the first of Chain Drug Review’s new series of video interviews, NACDS president and chief executive officer Steve Anderson talks about how the industry has responded to the challenge, the lessons being learned from the experience, and what the association’s priorities will be when
Entrenched assumptions about the role of community pharmacy are being uprooted by the COVID-19 crisis, and leaders of five of the nation’s largest retailers accelerated the process earlier this week during a meeting with President Trump and the Coronavirus Task Force at the White House. The executives were there to lend support to the public-private